India lifts ban on export of hydroxychloroquine
Part of: GS Prelims and GS-II – Health
- Indian government has ended its earlier ban on exporting of Hydroxychloroquine (HCQ).
- India would licence paracetamol and HCQ in appropriate quantities to all the neighbouring countries which are dependent on India’s capabilities.
- These essential drugs shall also be supplied to nations which are badly affected by the pandemic.
- Previously HCQ was placed on a restricted items list, and its export was completely banned in the first week of April.
- U.S. President Donald Trump had warned India of retaliation from U.S. if it withheld supplies of HCQ.
Important value additions:
- It is an anti-malarial drug.
- It is now being used by many countries as a possible line of treatment for COVID-19.
- It works by diminishing immune system’s response to viral infections.
- These dosages are also linked to instances of cardiac arrhythmia (Improper beating of the heart) and liver damage.
- A study in France showed that hydroxychloroquine alone or in combination with Azithromycin appeared to reduce virus levels quicker.
Why Hydroxychloroquine was completely banned?
- India imports Active Pharmaceutical Ingredient (API) from China for the manufacture of drugs at cheaper costs.
- The supply of APIs got affected due to COVID-19 outbreak in China.
- To ensure that India’s doesn’t fall short of supply for its own citizens, the drug was banned from exporting.
For further information, refer to this link: Drug Secutity
IASbaba imparts 360-degree IAS preparation solutions with their exhaustive Prelims and Mains preparation courses, supported by the latest UPSC preparation material. Avail our expert help by enrolling with us to keep your knowledge updated and stay ahead of your competition.
Most Trending and Trusted Programmes by UPSC Toppers :